An FDA panel has recommended approval of Second Sight Medical's Argus II retinal prosthesis system, according to a CBS Evening News report and Second Sight's website.
The Argus II, a "bionic eye", is intended to provide electrical stimulation of the retina to elicit visual perception in blind subjects with severe to profound retinitis pigmentosa, according to the company.
The implant is an epiretinal prosthesis surgically implanted in and on the eye that includes an antenna, an electronics case and an electrode array.
There have been only 30 people worldwide to test the device.
Related Articles on Ophthalmology:
Retina Group of Washington Opens VA Office in Vienna
TX's William Beaumont Army Medical Center Opens Eye Surgery Clinic
What's New With Ophthalmology? Q&A With Drs. Don Kikkawa and Robert Weinreb of the University of California San Diego's Shiley Eye Center